Company Overview

OneMedNet Corporation (NASDAQ: ONMD) is a healthcare technology and data enablement company focused on the aggregation, curation, and commercialization of clinical imaging and related healthcare data. The company operates primarily within the healthcare information technology, medical imaging, and real-world data analytics sectors. Its core platform is designed to provide researchers, life sciences companies, artificial intelligence developers, and healthcare organizations with access to de-identified medical imaging datasets and associated clinical information for research, product development, and regulatory applications.

The company’s primary business activities center on its imaging data network and software-driven infrastructure that facilitates compliant access to real-world clinical imaging data. OneMedNet is particularly focused on oncology, cardiology, neurology, and other disease areas where imaging data plays a central role in diagnostics and therapeutic development. The company traces its origins to efforts aimed at improving interoperability and secure data sharing between healthcare providers and research organizations. Over time, it evolved into a data commercialization and AI-enablement platform positioned around the growing demand for high-quality real-world medical imaging datasets.

Business Operations

OneMedNet generates revenue primarily through data licensing arrangements, platform access, imaging dataset delivery, and related healthcare data services. Its operational model centers on the management and commercialization of de-identified clinical imaging repositories collected from participating healthcare institutions. The company’s flagship platform, commonly associated with its iRWD-related imaging data infrastructure, is intended to support pharmaceutical companies, medical device manufacturers, AI developers, and academic researchers seeking access to curated imaging datasets for clinical research and machine learning model development.

The company operates through healthcare provider relationships and institutional data partnerships across the United States, with efforts aimed at expanding broader commercial and research participation. OneMedNet controls software systems and workflows related to data ingestion, anonymization, interoperability, and imaging archive management. Publicly available information indicates the company has established relationships with healthcare systems and imaging providers, although the scale and commercial contribution of individual partnerships are not consistently disclosed across public filings. Data regarding material joint ventures or large-scale international subsidiaries remains inconclusive based on available public sources.

Strategic Position & Investments

OneMedNet’s strategic direction is centered on expanding access to real-world imaging data for precision medicine, artificial intelligence training, and clinical research applications. The company has emphasized growth opportunities tied to increasing demand for high-quality, regulatory-compliant healthcare datasets as pharmaceutical and AI-driven healthcare development accelerates. Its positioning within imaging-focused real-world data distinguishes it from broader electronic health record and healthcare analytics providers that may not specialize in image-based datasets.

The company has pursued capital market activity and operational expansion following its public listing, with stated objectives that include increasing provider network participation, scaling data assets, and enhancing commercialization capabilities. Public disclosures reference investments in imaging data infrastructure and AI-oriented healthcare applications. While OneMedNet has discussed strategic expansion opportunities and platform development initiatives, publicly verifiable information regarding large acquisitions, international portfolio holdings, or significant minority investments remains limited. Data inconclusive based on available public sources regarding material acquisition history beyond disclosed financing and operational expansion activities.

Geographic Footprint

OneMedNet is headquartered in the United States and primarily operates within the domestic healthcare market. Its provider relationships and imaging data sourcing activities are concentrated across U.S.-based healthcare systems, hospitals, and clinical organizations. The company’s commercial focus aligns heavily with the U.S. life sciences, medical research, and healthcare AI ecosystem, where regulatory frameworks surrounding patient privacy and de-identified clinical data are central to operations.

Although the company’s data platform may support research collaborations with organizations operating internationally, publicly available filings and disclosures indicate that the majority of operational activity, infrastructure, and commercial focus remains U.S.-centric. Broader international operational influence or major foreign subsidiaries have not been extensively detailed in publicly available corporate disclosures.

Leadership & Governance

OneMedNet’s leadership team is composed of executives with backgrounds in healthcare technology, imaging systems, data management, and corporate finance. The company’s governance structure reflects its position as a publicly traded healthcare technology company focused on scaling data commercialization and research partnerships. Public communications and filings emphasize long-term growth through healthcare data accessibility, AI enablement, and institutional collaboration.

Key executives and leadership figures include:

• Aaron Green – President and Chief Executive Officer
• Paul Casey – Chief Financial Officer
• Matthew Moynahan – Chairman of the Board

The company’s leadership strategy has emphasized expanding the commercial utility of imaging data assets while maintaining compliance with healthcare privacy standards and supporting research innovation across the life sciences and medical AI sectors. Publicly available information regarding broader executive leadership structure may vary across filings and investor materials.